UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 185

Sortiert nach

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data

Neuro-oncology (Charlottesville, Va.), 2018-01, Vol.20 (2), p.184-191

2018

Link zum Volltext

Verfügbarkeit prüfen

MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas

Medical physics (Lancaster), 2016-06, Vol.43 (6), p.2835-2844

2016

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemical Detection of EGFRvIII in High Malignancy Grade Astrocytomas and Evaluation of Prognostic Significance

Journal of neuropathology and experimental neurology, 2004-07, Vol.63 (7), p.700-707

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect of the Addition of Chemotherapy to Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma: Secondary Analysis of RTOG 98-02

Journal of clinical oncology, 2014-02, Vol.32 (6), p.535-541

2014

Link zum Volltext

Verfügbarkeit prüfen

Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial

Journal of neurosurgery, 2008-11, Vol.109 (5), p.835-841

2008

Link zum Volltext

Verfügbarkeit prüfen

Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma

Neuro-oncology (Charlottesville, Va.), 2020-06, Vol.22 (6), p.830-837

2020

Link zum Volltext

Verfügbarkeit prüfen

Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial

Nature communications, 2024-01, Vol.15 (1), p.493-493, Article 493

2024

Link zum Volltext

Verfügbarkeit prüfen

Central Nervous System Tumors

Mayo Clinic proceedings, 2007-10, Vol.82 (10), p.1271-1286

2007

Link zum Volltext

Verfügbarkeit prüfen

Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2288-2294

2007

Link zum Volltext

Verfügbarkeit prüfen

Radiation Therapy Oncology Group 9802: Controversy or Consensus in the Treatment of Newly Diagnosed Low-Grade Glioma?

Seminars in radiation oncology, 2015-07, Vol.25 (3), p.197-202

2015

Link zum Volltext

Verfügbarkeit prüfen

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

The New England journal of medicine, 2016-04, Vol.374 (14), p.1344-1355

2016

Link zum Volltext

Verfügbarkeit prüfen

Central neurocytoma: Management recommendations based on a 35-year experience

International journal of radiation oncology, biology, physics, 2007-03, Vol.67 (4), p.1145-1154

2007

Link zum Volltext

Verfügbarkeit prüfen

Cognitive function after radiotherapy for supratentorial low-grade glioma: A North Central Cancer Treatment Group prospective study

International journal of radiation oncology, biology, physics, 2005-11, Vol.63 (4), p.1175-1183

2005

Link zum Volltext

Verfügbarkeit prüfen

Effects of Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma Measured by the Folstein Mini-Mental State Examination

Journal of clinical oncology, 2003-07, Vol.21 (13), p.2519-2524

2003

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Procarbazine, Lomustine, and Vincristine as Initial Therapy for Patients With Low-Grade Oligodendroglioma or Oligoastrocytoma: Efficacy and Associations With Chromosomal Abnormalities

Journal of clinical oncology, 2003-01, Vol.21 (2), p.251-255

2003

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Follow-Up of Dose-Adapted and Reduced-Field Radiotherapy With or Without Chemotherapy for Central Nervous System Germinoma

International journal of radiation oncology, biology, physics, 2010-08, Vol.77 (5), p.1449-1456

2010

Link zum Volltext

Verfügbarkeit prüfen

Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH

Journal of clinical oncology, 2014-03, Vol.32 (8), p.783-790

2014

Link zum Volltext

Verfügbarkeit prüfen

Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status

Journal of digital imaging, 2017-10, Vol.30 (5), p.622-628

2017

Link zum Volltext

Verfügbarkeit prüfen

Detrimental Effects of Tumor Progression on Cognitive Function of Patients With High-Grade Glioma

Journal of clinical oncology, 2006-12, Vol.24 (34), p.5427-5433

2006

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant nitrosoureas: will they ever go away?

Neuro-oncology (Charlottesville, Va.), 2017-02, Vol.19 (2), p.145-146

Buckner, Jan C

2017

Link zum Volltext

Verfügbarkeit prüfen

Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status

Journal of digital imaging, 2017-10, Vol.30 (5), p.622-628

2017

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the Optimal Number of Lesions Needed for Tumor Evaluation Using the Response Evaluation Criteria in Solid Tumors: A North Central Cancer Treatment Group Investigation

Journal of clinical oncology, 2009-07, Vol.27 (19), p.3205-3210

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial of Carmustine and Cisplatin Compared With Carmustine Alone and Standard Radiation Therapy or Accelerated Radiation Therapy in Patients With Glioblastoma Multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials

Journal of clinical oncology, 2006-08, Vol.24 (24), p.3871-3879

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 185

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(175)
Mit Volltextzugriff
(172)

Publikationsform

Sprache

Englisch
(185)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(110)
Life Sciences & Biomedicine
(107)
Humans
(94)
Oncology
(75)
Biological And Medical Sciences
(44)
Medical Sciences
(44)
Female
(43)
Male
(43)
Adult
(34)
Clinical Neurology
(34)
Neurosciences & Neurology
(34)
Middle Aged
(28)
Neurology
(25)
Brain Neoplasms - Drug Therapy
(23)
Brain Neoplasms - Radiotherapy
(20)
Tumors
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(19)
Chemotherapy
(19)
Prognosis
(18)
Treatment Outcome
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data

MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas

Immunohistochemical Detection of EGFRvIII in High Malignancy Grade Astrocytomas and Evaluation of Prognostic Significance

Effect of the Addition of Chemotherapy to Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma: Secondary Analysis of RTOG 98-02

Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial

Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma

Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial

Central Nervous System Tumors

Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma

Radiation Therapy Oncology Group 9802: Controversy or Consensus in the Treatment of Newly Diagnosed Low-Grade Glioma?

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

Central neurocytoma: Management recommendations based on a 35-year experience

Cognitive function after radiotherapy for supratentorial low-grade glioma: A North Central Cancer Treatment Group prospective study

Effects of Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma Measured by the Folstein Mini-Mental State Examination

Phase II Trial of Procarbazine, Lomustine, and Vincristine as Initial Therapy for Patients With Low-Grade Oligodendroglioma or Oligoastrocytoma: Efficacy and Associations With Chromosomal Abnormalities

Long-Term Follow-Up of Dose-Adapted and Reduced-Field Radiotherapy With or Without Chemotherapy for Central Nervous System Germinoma

Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH

Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status

Detrimental Effects of Tumor Progression on Cognitive Function of Patients With High-Grade Glioma

Adjuvant nitrosoureas: will they ever go away?

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma

Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status

Evaluation of the Optimal Number of Lesions Needed for Tumor Evaluation Using the Response Evaluation Criteria in Solid Tumors: A North Central Cancer Treatment Group Investigation

Phase III Trial of Carmustine and Cisplatin Compared With Carmustine Alone and Standard Radiation Therapy or Accelerated Radiation Therapy in Patients With Glioblastoma Multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials

Aktive Filter

Suchergebnisse filtern